Market closedNon-fractional
Sol-Gel Technologies/SLGL
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Sol-Gel Technologies
Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.
Ticker
SLGL
Sector
Healthcare
Trading on
NASDAQ
Industry
Pharmaceuticals
Headquarters
Ness Ziona, Israel
Employees
36
Website
www.sol-gel.com
SLGL Metrics
BasicAdvanced
$13M
Market cap
-
P/E ratio
-$0.83
EPS
1.54
Beta
-
Dividend rate
Price and volume
Market cap
$13M
Beta
1.54
Financial strength
Current ratio
6.891
Quick ratio
6.485
Long term debt to equity
3.47
Total debt to equity
4.652
Management effectiveness
Return on assets (TTM)
-35.07%
Return on equity (TTM)
-59.60%
Valuation
Price to revenue (TTM)
7.276
Price to book
0.38
Price to tangible book (TTM)
0.38
Growth
Revenue change (TTM)
-62.92%
Earnings per share change (TTM)
-1.09%
3-year revenue growth (CAGR)
-34.09%
3-year earnings per share growth (CAGR)
-10.22%
What the Analysts think about SLGL
Analyst Ratings
Majority rating from 2 analysts.
SLGL Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$400K
0.00%
Net income
-$6.3M
31.25%
Profit margin
-1,575.00%
31.25%
SLGL Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.22
-$0.21
-$0.17
-$0.23
-
Expected
-$0.26
-$0.23
-$0.18
-$0.15
-$0.20
Surprise
-13.73%
-8.70%
-2.86%
53.33%
-
SLGL News
AllArticlesVideos
Sol-Gel Technologies Announces Management Realignment
GlobeNewsWire·2 weeks ago
Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates
GlobeNewsWire·2 months ago
Sol-Gel and Beimei Pharma Announce an Asset Purchase Agreement to Commercialize TWYNEO® in the Mainland of China, Hong Kong, Macau, Taiwan and Israel
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sol-Gel Technologies stock?
Sol-Gel Technologies (SLGL) has a market cap of $13M as of July 27, 2024.
What is the P/E ratio for Sol-Gel Technologies stock?
The price to earnings (P/E) ratio for Sol-Gel Technologies (SLGL) stock is 0 as of July 27, 2024.
Does Sol-Gel Technologies stock pay dividends?
No, Sol-Gel Technologies (SLGL) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Sol-Gel Technologies dividend payment date?
Sol-Gel Technologies (SLGL) stock does not pay dividends to its shareholders.
What is the beta indicator for Sol-Gel Technologies?
Sol-Gel Technologies (SLGL) has a beta rating of 1.54. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Sol-Gel Technologies stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.